TG103
A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes
CSPC Baike (Shandong) Biopharmaceutical Co · Phase 2 · Status n/r · Enrollment 208
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.